Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
PDF Solutions
PDFS
$2.15B
| $1.01M | ﹤0.01% |
23,800
-21,100
| -47% | -$739K |
|
2477
Paymentus
PAY
$5.27B
| $999K | ﹤0.01% |
112,800
-24,600
| -18% | -$208K |
|
2478
Eagle Bancorp Montana
EBMT
$187M
| $998K | ﹤0.01% |
70,710
-4,700
| -6% | -$77.5K |
|
2479
State Street SPDR ICE Preferred Securities ETF
PSK
$683M
| $998K | ﹤0.01% |
+29,400
| New | +$1.03M |
|
2480
State Street SPDR S&P Metals & Mining ETF
XME
$4.53B
| $994K | ﹤0.01% |
+18,700
| New | +$1.02M |
|
|
ARVL
2481
DELISTED
Arrival Ordinary Shares
ARVL
| $993K | ﹤0.01% |
148,155
-169,611
| -53% | -$2.5M |
|
|
VTYX
2482
DELISTED
Ventyx Biosciences
VTYX
| $992K | ﹤0.01% |
29,600
+22,800
| +335% | +$887K |
|
|
PRVB
2483
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $991K | ﹤0.01% |
+41,100
| New | +$516K |
|
2484
Valmont Industries
VMI
$9.56B
| $990K | ﹤0.01% |
+3,100
| New | +$989K |
|
2485
OP Bancorp
OPBK
$233M
| $989K | ﹤0.01% |
111,042
-30,390
| -21% | -$328K |
|
2486
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $985K | ﹤0.01% |
21,600
-21,800
| -50% | -$992K |
|
2487
Xeris Biopharma Holdings
XERS
$1.57B
| $984K | ﹤0.01% |
603,894
+105,400
| +21% | +$132K |
|
2488
RGC Resources
RGCO
$224M
| $982K | ﹤0.01% |
42,333
-9,406
| -18% | -$222K |
|
|
KG
2489
Kestrel Group
KG
$61.7M
| $979K | ﹤0.01% |
23,425
+435
| +2% | +$20.2K |
|
2490
Kraft Heinz
KHC
$30.3B
| $978K | ﹤0.01% |
25,281
-295,900
| -92% | -$11.7M |
|
2491
InnovAge Holding
INNV
$1.44B
| $977K | ﹤0.01% |
122,400
+2,200
| +2% | +$15.9K |
|
2492
Microvast
MVST
$322M
| $977K | ﹤0.01% |
787,530
+599,870
| +320% | +$871K |
|
|
AIOT
2493
PowerFleet Inc
AIOT
$417M
| $977K | ﹤0.01% |
284,810
+2,900
| +1% | +$8.11K |
|
2494
iShares MSCI Indonesia ETF
EIDO
$489M
| $976K | ﹤0.01% |
41,500
-85,900
| -67% | -$1.96M |
|
2495
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $973K | ﹤0.01% |
15,600
+7,400
| +90% | +$455K |
|
2496
Clearfield
CLFD
$391M
| $972K | ﹤0.01% |
20,874
-63,784
| -75% | -$4.11M |
|
2497
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $971K | ﹤0.01% |
+30,100
| New | +$966K |
|
2498
Curis
CRIS
$3.76M
| $970K | ﹤0.01% |
4,069
+247
| +6% | +$65.1K |
|
|
AVNS
2499
DELISTED
Avanos Medical
AVNS
| $967K | ﹤0.01% |
32,500
+10,900
| +50% | +$316K |
|
2500
Actinium Pharmaceuticals
ATNM
$32.6M
| $966K | ﹤0.01% |
102,200
-57,400
| -36% | -$606K |
|
Similar funds
Jim Simons's Q1 2023 Portfolio in Review
As of Q1 2023, Jim Simons held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Jim Simons added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Jim Simons's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Jim Simons fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Jim Simons's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Jim Simons opened 524 new positions and closed 668 in Q1 2023.
- Jim Simons's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.